Report: Anderson Silva Failed Second UFC 183 Drug Test

Georges St. Pierre warned that the performance-enhancing drug (PED) epidemic in MMA would get worse before it got better, and well, he was one hundred percent correct.

After disappointing news broke last week that longtime UFC middleweight champion Anderson Silva had tested positive for the steroids drostanolone and androstane in an out-of-competition (OOC) test on January 9 prior to his UFC 183 win over Nick Diaz, his many fans were relieved to learn that he indeed passed a second test administered on January 19.

Yet tonight, those fans are going to have to unfortunately pump their brakes, as MMA Junkie has reported that a source close to the situation has confirmed that Silva failed a second drug test in conjunction with UFC 183.

The source remained anonymous on the condition that they were unable to publicly discuss the matter, and an open-records request to the state of Nevada has not yet been returned.

Silva is scheduled to appear at next week’s (Mon., February 17, 2014) Nevada Athletic Commission (NAC) hearing alongside Diaz, who failed an in-contest drug test for marijuana metabolites at UFC 183.

But both fighters, who will join fellow drug test failures Hector Lombard and Ashlee Evans-Smith, will most likely earn only a temporary suspension leading to full punishments at a later hearing date.

It’s been a trying (to say the least) start to 2015 for the UFC, and that was the last thing they needed after a down 2014 that saw profits drop considerably.

Perhaps it’s time for them to take a stand and make the punishments for using PEDs so harsh that using them simply won’t be worth the risk. UFC president Dana White and co-owner Lorenzo Fertitta have a press conference scheduled for next week (Tues., February 18, 2015) to discuss their unfolding epidemic, but is it already too late?

Photo Credit: Jayne Kamin-Oncea-USA TODAY Sports